442 K.P. Lindsey et al.
Mathew RJ, Wilson WH, Chiu NY, Turkington TG, Degrado TR, Coleman RE (1999) Regional
cerebral blood flow and depersonalization after tetrahydrocannabinol administration.
Acta Psychiatr Scand 100:67–75
Mathew RJ, Wilson WH, Turkington TG, Hawk TC, Coleman RE, DeGrado TR, Provenzale J
(2002) Time course of tetrahydrocannabinol-induced changes in regional cerebral blood
flow measured with positron emission tomography. Psychiatry Res 116:173–185
Mathews WB, Scheffel U, Finley P, Ravert HT, Frank RA, Rinaldi-Carmona M, Barth F,
Dannals RF (2000) Biodistribution of [18F] SR144385 and [18F] SR147963: selective
radioligands for positron emission tomographic studies of brain cannabinoid receptors.
Nucl Med Biol 27:757–762
Mathews WB, Scheffel U, Rauseo PA, Ravert HT, Frank RA, Ellames GJ, Herbert JM, Barth
F, Rinaldi-Carmona M, Dannals RF (2002) Carbon-11 labeled radioligands for imaging
brain cannabinoid receptors. Nucl Med Biol 29:671–677
O’Leary DS, Block RI, Flaum M, Schultz SK, Boles Ponto LL, Watkins GL, Hurtig RR,
Andreasen NC, Hichwa RD (2000) Acute marijuana effects on rCBF and cognition:
a PET study. Neuroreport 11:3835–3841
O’Leary DS, Block RI, Koeppel JA, Flaum M, Schultz SK, Andreasen NC, Ponto LB, Watkins
GL, Hurtig RR, Hichwa RD (2002) Effects of smoking marijuana on brain perfusion and
cognition. Neuropsychopharmacology 26:802–816
O’Leary DS, Block RI, Turner BM, Koeppel J, Magnotta VA, Ponto LB, Watkins GL, Hichwa
RD, Andreasen NC (2003) Marijuana alters the human cerebellar clock. Neuroreport
14:1145–1151
Oviedo A, Glowa J, Herkenham M (1993) Chronic cannabinoid administration alters
cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Brain
Res 616:293–302
Phelps ME (1991) PET: a biological imaging technique. Neurochem Res 16:929–940
Pontieri FE, Conti G, Zocchi A, Fieschi C, Orzi F (1999) Metabolic mapping of the effects
of WIN 55212–2 intravenous administration in the rat. Neuropsychopharmacology
21:773–776
Porrino LJ (1993) Functional consequences of acute cocaine treatment depend on route of
administration. Psychopharmacology (Berl) 112:343–351
Raichle ME, Martin WR, Herscovitch P, Mintun MA, Markham J (1983) Brain blood flow
measured with intravenous H2(15)O. II. Implementation and validation. J Nucl Med
24:790–798
ReivichM,KuhlD,WolfA,GreenbergJ,PhelpsM,IdoT,CasellaV,FowlerJ,GallagherB,
Hoffman E, Alavi A, Sokoloff L (1977) Measurementof local cerebral glucose metabolism
in man with 18F-2-fluoro-2-deoxy-d-glucose. Acta Neurol Scand Suppl 64:190–191
Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S,
Maruani J, Neliat G, Caput D, et al (1994) SR141716A, a potent and selective antagonist
of the brain cannabinoid receptor. FEBS Lett 350:240–244
Rogers A (1973) Techniques of autoradiography, 2nd edn. Elsevier Scientific Publishing
Company, Amsterdam
Romero J, Garcia-Palomero E, Castro JG, Garcia-Gil L, Ramos JA, Fernandez-Ruiz JJ (1997)
Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor
binding and mRNA levels in several rat brain regions. Brain Res Mol Brain Res 46:100–
108
Romero J, Berrendero F, Manzanares J, Perez A, Corchero J, Fuentes JA, Fernandez-Ruiz
JJ, Ramos JA (1998) Time-course of the cannabinoid receptor down-regulation in the
adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol. Synapse
30:298–308
Rubino T, Vigano D, Massi P, Spinello M, Zagato E, Giagnoni G, Parolaro D (2000) Chronic
delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent
protein kinase activity in some rat brain regions. Neuropharmacology 39:1331–1336
Sakurada O, Kennedy C, Jehle J, Brown JD, Carbin GL, Sokoloff L (1978) Measurement of
local cerebral blood flow with iodo [14C] antipyrine. Am J Physiol 234:H59–66